Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

NCT03113825 is registered in ClinicalTrials.gov with Avelas Biosciences, Inc. as lead sponsor.

NCT NCT03113825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03113825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Lead sponsor
Avelas Biosciences, Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 5, 2017
Completion date
November 18, 2020
Enrollment
92 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female, carcinoma breast, carcinoma, ductal, breast, primary invasive malignant neoplasm of female breast, stage i breast cancer, stage ii breast cancer, stage iii breast cancer